A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
1. Verfasser: | Islam, Nahidul |
---|---|
Weitere Verfasser: | Talukder, Mesbah |
Format: | Abschlussarbeit |
Sprache: | English |
Veröffentlicht: |
Brac University
2023
|
Schlagworte: | |
Online Zugang: | http://hdl.handle.net/10361/22025 |
Ähnliche Einträge
-
TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study
von: Afroza, Halima
Veröffentlicht: (2024) -
Biologics and Biosimilars as Treatment Options for Psoriasis
von: Moya, Amena Khatun
Veröffentlicht: (2023) -
Association of GLP-1 receptor agonists and risk of pancreatitis: a pharmacovigilance study based on FAERS database
von: Bishakha, Adwiza Chakraborty
Veröffentlicht: (2024) -
Safety and efficacy of dutasteride for male Androgenetic Alopecia
von: Islam, S.M. Zahidul
Veröffentlicht: (2024) -
Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
von: Khandker, Tahia Anjum
Veröffentlicht: (2024)